EP 1208195 A2 20020529 - SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
Title (en)
SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
Title (de)
AUSGESCHIEDENE UND TRANSMEMBRAN-POLYPEPTIDE UND DAFÜR KODIERENDE NUKLEINSÄURE
Title (fr)
POLYPEPTIDES SECRETES ET TRANSMEMBRANAIRES ET ACIDES NUCLEIQUES CODANT POUR CEUX-CI
Publication
Application
Priority
- US 0014042 W 20000522
- US 13969599 P 19990615
- US 14507099 P 19990720
- US 14569899 P 19990726
- US 14939699 P 19990817
- US 9920111 W 19990901
- US 9920594 W 19990908
- US 9921090 W 19990915
- US 9921547 W 19990915
- US 9928313 W 19991130
- US 9928301 W 19991201
- US 9928565 W 19991202
- US 16949599 P 19991207
- US 0000219 W 20000105
- US 0004341 W 20000218
- US 0004342 W 20000218
- US 0004414 W 20000222
- US 0005601 W 20000301
- US 0005841 W 20000302
- US 0007377 W 20000320
- US 0008439 W 20000330
- US 0013358 W 20000515
- US 0013705 W 20000517
Abstract (en)
[origin: WO0077037A2] The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
IPC 1-7
C12N 15/12; C07K 14/47; C07K 14/705; C12N 15/62; C07K 16/18; C07K 16/28; G01N 33/53
IPC 8 full level
C07K 14/47 (2006.01); G01N 33/53 (2006.01); A61K 31/7088 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); A61P 43/00 (2006.01); C07K 14/00 (2006.01); C07K 14/705 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C07K 19/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12N 15/62 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01); G01N 33/566 (2006.01); G01N 33/574 (2006.01); G01N 33/577 (2006.01); G01N 33/58 (2006.01)
CPC (source: EP)
A61P 3/04 (2017.12); A61P 3/10 (2017.12); A61P 7/00 (2017.12); A61P 9/00 (2017.12); A61P 9/04 (2017.12); A61P 13/12 (2017.12); A61P 17/02 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 25/00 (2017.12); A61P 27/02 (2017.12); A61P 27/16 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); A61P 37/04 (2017.12); A61P 43/00 (2017.12); C07K 14/47 (2013.01); C07K 14/495 (2013.01)
Citation (search report)
See references of WO 0077037A2
Citation (examination)
WO 9914328 A2 19990325 - GENENTECH INC [US], et al
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0077037 A2 20001221; WO 0077037 A3 20020228; AT E448246 T1 20091115; AT E449109 T1 20091215; CA 2372511 A1 20001221; CA 2372511 C 20111122; EP 1208195 A2 20020529; JP 2003529324 A 20031007; JP 2006025795 A 20060202; JP 2006051031 A 20060223; JP 2006051032 A 20060223; JP 2006061156 A 20060309; JP 2006068006 A 20060316
DOCDB simple family (application)
US 0014042 W 20000522; AT 07025116 T 20000522; AT 07025118 T 20000522; CA 2372511 A 20000522; EP 00936172 A 20000522; JP 2001503894 A 20000522; JP 2005235120 A 20050815; JP 2005238217 A 20050819; JP 2005238244 A 20050819; JP 2005238266 A 20050819; JP 2005238274 A 20050819